Delivery Order SPE2DB20D1109-SPE2DB23FP31H
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,588.37 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Ciproflox-Dexameth Otic Suspension 7.5ML. This is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a ceiling value of $4,773.95 and an ultimate completion date of December 27, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,536.62 and an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,140.36, is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a performance period ending on July 26, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,085.03 for the pharmaceutical product Ciproflox-Dexameth Otic Suspension (7.5 ml). The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Ciproflox-Dexameth Otic Suspension 7.5ml. The contract has a ceiling value of $1,508.15 and is a firm fixed-price delivery order with a completion date of June 9, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,265.44, is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 ml) to support military healthcare programs. The award, which has a completion date of April 12, 2022, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ciproflox-Dexameth Otic Suspension 7.5ML, a pharmaceutical product, with a ceiling value of $5,379.73 and a completion date of September 19, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation. Amerisourcebergen Drug Corp is a major...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ciproflox-Dexameth Otic Suspension 7.5 mL. The contract has a ceiling value of $1,269.03 and an ultimate completion date of June 26, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
- This federal contract award is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 mL) to the Defense Logistics Agency (DLA). The $3,215.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP31HDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a ceiling value of $1,105.36 and runs through June 13, 2023. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/12/23 |